NYSE$CTEV

Claritev Corp · Q2 2025 earnings

Q2 2025 earnings · · Before market open · Investor relations

Briefing

Claritev Corp reported Q2 2025 revenues of $241.6 million with a net loss of $62.6 million.

Claritev Corp posted Q2 2025 revenues of $241.6 million, up 3.5% year-over-year, driven by growth in Network-Based and Payment and Revenue Integrity Services. The company recorded operating income of $16.6 million but a net loss of $62.6 million due to high interest expense. Medical charges processed totaled $43.8 billion with potential savings of $6.3 billion identified.

  • Q2 revenues reached $241.6 million, a 3.5% increase from Q2 2024.
  • Net loss narrowed to $62.6 million from $576.7 million in the prior-year quarter after a large goodwill impairment in 2024.
  • Operating income turned positive at $16.6 million versus a $523.9 million loss last year.
  • Total medical charges processed were $43.8 billion, generating $6.3 billion in potential savings.

Headline financials

Total Revenue

$242M

Previous: $233M+3.5%
EPS (adj)

-$3.81

Previous: -$0.89-328.1%
Medical charges processed

$43.8B

No prior period
Potential medical cost savings

$6.29B

No prior period
Capital Expenditures

-$63.5M

Previous: -$56M-13.4%
Net Income

-$62.6M

Previous: -$577M+89.1%
Operating Income

$16.6M

Previous: -$524M+103.2%
Cash & Equivalents

$56.4M

Previous: $48.8M+15.6%
Total Assets

$5.07B

Previous: $5.74B-11.7%

Revenue & EPS history

Multiplan · Revenue · Quarterly

$242M

Q2 2025+3.5%vs Q2 2024
Beat estimate in 9 of 14 quarters(64%)
ActualEstimate

Revenue by segment

Multiplan · $242M total across 3 segments · Q2 2025

  • Analytics-Based Services
    $157M
  • Network-Based Services
    $54.1M
  • Payment and Revenue Integrity Services
    $30.5M

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports

Historical avg

-6.5%

Avg return

Earnings day

-5.1%

Avg return

5 days after

-3.8%

Avg return

30 days after

36%

9 / 25 earnings

Positive

+20.8%

Q1 2021

Best reaction

-32.8%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2025
Q1 2026-8.8%+7.7%-2.6%
Q4 2025-31.8%-42.0%-31.4%
Q3 2025+11.8%-5.4%-45.2%
Q1 2025+4.2%+7.5%+95.1%
Q4 2024-32.8%-28.1%-24.8%
Q3 2024-6.5%-3.4%-22.6%
Q2 2024-23.9%-10.2%-47.8%
Q1 2024+10.9%-1.5%-36.6%
Q4 2023-0.9%-13.4%-27.6%
Q3 2023-6.5%-9.7%-14.3%
Q2 2023-8.9%-14.0%-17.8%
Q1 2023-5.4%+21.0%+97.6%
Q4 2022-10.2%+10.0%+6.0%
Q3 2022-27.8%-18.3%-31.1%
Q2 2022-12.4%-13.4%-33.1%
Q1 2022+1.0%+18.4%+27.4%
Q4 2021-8.0%-18.9%-14.4%
Q3 2021+0.2%-11.0%-4.3%
Q2 2021-6.2%-10.5%-20.6%
Q1 2021+20.8%+27.0%+45.5%
Q2 2020+0.5%-0.2%+1.9%
Q4 2020-18.6%-20.3%-19.7%
Q3 2020-4.6%+0.7%+20.8%
Q1 2020+0.5%+0.7%+2.3%
Q4 2019+0.5%+0.7%+2.3%
Q3 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro